Skip to content

Safety and Efficacy Evaluation Study of Brucea javanica oil in the Treatment of Advanced Gastric Cancer

Safety and efficacy evaluation study of Brucea javanica oil in the treatment of advanced gastric cancer

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000028933
Enrollment
Unknown
Registered
2020-01-08
Start date
2020-01-07
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Test Group:Brucea Javanica Oil

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients with advanced gastric cancer confirmed by pathology and / or cytology; 2) There were evaluable lesions; 3) Aged > 18 years, gender unlimited; 4) The physical condition of the patients was good, and the score of kappa was >= 60; 5) It has the indication of maintaining chemotherapy, and the curative effect of palliative chemotherapy reaches SD or PR patients; 6) Signed the informed consent voluntarily, and had good compliance with the treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1) Patients with severe impairment of heart, liver and kidney function, hematopoietic dysfunction and mental disorder; 2) Patients with uncontrolled diabetes, hypertension and ulcer; patients with uncontrolled infection; 3) Patients with poor compliance; 4) People with allergic constitution and patients who are known or suspected to be allergic to any investigational drug; 5) Patients who participated in clinical trials of other drugs in the past month; 6) Pregnant and lactating women; 7) The researchers think it is not suitable to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
1 year survival rate;

Secondary

MeasureTime frame
Side effects of chemotherapy;Life status score;Immune function;Gastric cancer symptom score;

Countries

China

Contacts

Public ContactLing Binxun

Jiangsu Cancer Hospital

lingbinxun@163.com+86 13913985619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026